User Profile
Select your user profile
Roche receives FDA approval for the first companion diagnostic to identify patients with gastric and gastroesophageal junction cancer eligible for targeted treatment with VYLOY
Pathology Lab

Roche expands companion diagnostic portfolio with FDA approval of CLDN18 assay

The new VENTANA CLDN18 (43-14A) RxDx Assay helps fulfill an unmet medical need by enabling clinicians to identify patients with gastric or gastroesophageal junction (GEJ) cancer.

Latest news

 

Roche claims six 2024 IMV ServiceTrak Clinical Laboratory Awards at ALDM for Core Lab satisfaction, system performance and service performance
Customer Satisfaction
Roche claims six 2024 IMV ServiceTrak Clinical Laboratory Awards

We're recognized as No. 1 in service for both Clinical Chemistry and Integrated Workstation systems, in Core Lab customer satisfaction, system performance and service performance.

Learn more
Roche receives FDA clearance on its digital pathology solution for diagnostic use
Pathology Lab
Roche receives FDA clearance on its digital pathology solution for diagnostic use

The VENTANA DP 200 slide scanner is now cleared to aid in clinical diagnosis, enabling pathologists to diagnose patients using digital images.

Learn more

Roche four-in-one molecular test for SARS-CoV-2, Influenza A/B viruses and RSV receives U.S. FDA Emergency Use Authorization
Respiratory
Four-plex test for SARS-CoV-2, Influenza A/B and RSV receives FDA Emergency Use Authorization

Now, HCPs will be able to detect and differentiate these respiratory viruses within a single patient visit, enabling improved public health outcomes.

Learn more

Related links

Products

Learn more about our portfolio of lab instruments, systems, assays and more  

Begin exploring

Documents

More than 800,000 documents available on demand — always up-to-date with 24/7 access

Log in to eLabDoc

Education

Empowering learning — e-learning content, PACE/CEU courses, and more

Start training